The Venture Codex

Participated · Series C · Jan 2026

Nuclera is a biotechnology company building eProtein Discovery, a desktop platform that integrates cell-free protein expression, digital microfluidics, and high-throughput screening to give researchers rapid access to purified proteins. The system reduces the time, cost, and uncertainty of protein production, allowing scientists to identify and validate candidates earlier in the drug-discovery process. With its latest focus on AI-enabled protein engineering, Nuclera is adding antibody-specific capabilities so users can perform end-to-end expression, purification, and binding validation of full-format antibodies on the same device. These new features are designed to generate large, standardized data sets suitable for training advanced machine-learning models in biologics R&D. Management positions the platform as a foundational tool for the fast-growing biologics segment, aiming to shorten therapeutic discovery timelines. The firm’s ongoing development is backed by considerable venture financing, now totaling $87 million in Series C capital.

Participated · Equity · Dec 2025

Blykalla is an advanced nuclear-technology company focused on the SEALER reactor, a compact, lead-cooled fast reactor intended to provide stable, emission-free baseload electricity. The company positions SEALER for both national grids and rapidly growing hyperscale data-center markets whose power needs are increasing with AI adoption. With its latest funding, Blykalla will scale verification and validation activities at the Advanced Reactor Testing Site in Oskarshamn, progress detailed design and construction of its first reactor unit, and accelerate commercial and regulatory work to secure a deployment site and permits. A newly signed Joint Technical Development Agreement with U.S. reactor developer Oklo enables the two firms to coordinate licensing, component procurement, fuel supply, and broader supply-chain efforts, aiming to shorten timelines and reduce risk. Strategically, Blykalla also taps expertise from industrial partners such as Uniper, KSB, and ABB. The company has now raised an additional $50 million, strengthening its balance sheet as it moves toward initial deployment; no revenue or customer metrics were disclosed in the articles.

Participated · Seed · Oct 2025

Kneu Health turns everyday smartphone interactions—voice, movement and memory tests—into clinically validated biomarkers that help clinicians detect neurological decline earlier and guide personalized interventions. Built on one of the world’s largest Parkinson’s and dementia datasets, the platform has collected more than 500,000 digital measures from 1,400+ users across NHS and U.S. deployments. Its FDA-cleared tremor measurement tool allows continuous, remote monitoring without additional hardware, embedding longitudinal data directly into clinical workflows. Reported outcomes include 67% faster-than-standard access to treatment, medication adjustments in over half of monitored patients, and up to 30% improvements in patient knowledge, confidence and self-management. NHS pilots cite a 30% boost in efficiency, reductions in emergency admissions and the equivalent of 1,000 hospital bed days saved. With contracts already underway at Cedars-Sinai and Mass General Brigham, Kneu plans to use new capital to scale U.S. Parkinson’s deployments, expand commercial capacity and advance its dementia monitoring capabilities. The latest financing brings its total funding to $11.2 million, supporting the company’s goal of making continuous neurological care core infrastructure for health systems.

Participated · Equity · Sep 2023

Navenio builds an indoor location and AI tasking platform that uses only a smartphone’s sensors and a fusion of four technologies to deliver real-time location awareness of patients, staff and equipment. Its ‘Intelligent Location and Workforce Solutions’ combine mapping, route optimisation and a tasking engine to automate orchestration of patient care and resource allocation. The platform surfaces actionable insights such as over- or under-utilization of staff and equipment to improve operational efficiency and revenue opportunities. Navenio cites customer outcomes including a 66% increase in portering efficiency and improved patient flow at University Hospitals of Leicester NHS Trust. The company was spun out of the University of Oxford in 2015 and has an established team of more than 60 people. It is certified or compliant with Cyber Essentials Plus, GDPR, HIPAA and the NHS Data Security and Protection Toolkit. Navenio develops infrastructure-free indoor location technology that uses only smartphone sensors, fusing four technologies to provide GPS-equivalent positioning inside buildings. Its platform powers apps and platforms across healthcare and other verticals and it has partnerships with health systems, facilities management operators, and HERE Technologies. The company says its tools can increase workplace productivity by up to 100%, helping maximise patient flow in departments such as imaging and logistics. Navenio was spun out of the University of Oxford in 2015 and has an established team of more than 60 people. It holds Cyber Essentials Plus certification and is GDPR, HIPAA and NHS Data Security and Protection Toolkit compliant. The recent funding will be used to accelerate US expansion and continued domestic growth while the company builds a nationally scalable evidence base supported by recent NHSX funding. Navenio is an Oxford-based healthcare scale-up that builds location-based technology to optimise hospital workflows. Its system has been shown to double the throughput of hospital teams by prioritising tasks for individual staff. The company focuses on improving patient flow within hospitals and easing operational pressures. In response to the COVID-19 pandemic, Navenio is applying its technology to help hospitals prepare and manage rising case loads. The firm recently secured targeted public funding to support these efforts and continue deployment across UK hospitals. Navenio builds an AI-powered indoor localization platform that uses smartphone sensors, sensor fusion, and probabilistic map-matching to locate people in multi-floor buildings where GPS fails. Its core technology leverages pedestrian dead reckoning (PDR) from accelerometers and magnetometers plus ambient signal maps derived from Wi‑Fi and Bluetooth. The system can be deployed on-device or in the cloud, integrates with third-party apps, and Navenio also provides its own app to expose the location engine. The company is developing crowdsourced auto-mapping (piloting in two U.K. projects) to generate floor plans from user movements and automatically adapts to changes in radio signals. Navenio is currently focused on healthcare, with 13 hospital sites in the U.K. under contract and use cases including locating cleaners and porters, routing staff, and tracking patients during transport. Founded in 2015 as a University of Oxford spinout, the company raised £9 million ($11 million) in Series A funding to grow its commercial footprint and support international expansion.

Participated · Series B · Dec 2022

UnaBiz is a Singapore-based IoT solutions operator that builds customizable, large-scale deployments using low-power wide-area network (LP-WAN) technology. Its core offerings target smart metering, facilities management, asset tracking, and asset management. The company operates an integrated solution ecosystem in Taiwan and maintains an innovation platform in Singapore. UnaBiz has made significant progress in water and gas metering, asset tracking, and facilities management. The company announced completion of a $25 million Pre-C financing. That financing was provided by KDDI Open Innovation Fund III (KOIF III) and Kyocera Communication Systems (KCCS). UnaBiz is a Singapore-based Massive Internet of Things (IoT) service provider and the owner of Sigfox's technology. The company provides low-power wide-area network (LPWAN) connectivity and 0G capabilities and plans to expand its product portfolio to include more LPWAN and satellite technology. After acquiring Sigfox's tech in April, UnaBiz doubled its office locations and tripled headcount to more than 240 employees, and it closed down Sigfox's loss-making entities while bringing in new executives including a chief customer officer, chief operating officer, and chief technology officer. UnaBiz plans to target four verticals—utilities, security, facilities management, and supply chain and logistics—across Latin America, APAC and EMEA. The company said it will use new capital to prepare for its next stage of growth, focus on driving commercial activities and delivery to customers in 2023, and invest in research and development for its 0G capabilities. UnaBiz has now raised $60 million in total. UnaBiz is a licensed IoT operator and the official Sigfox operator in Singapore and Taiwan. The company provides Sigfox connectivity and sells end-to-end IoT solutions enabled by its network, along with professional consultation services to startups and corporations. It serves industry verticals including aerospace, facilities management, food and beverage, logistics, security, supply chain and smart cities. In two years UnaBiz has rolled out two national networks, built an ecosystem of over 200 partners across Asia, signed deals in over 25 countries and is connecting devices across five continents. Led by CEO and founder Henri Bong, the company intends to use the new funds to develop IoT applications that combine connectivity, end-to-end solutions and engineering services. The article reports UnaBiz raised over USD10m in Series A funding.